Finally, the molecular roles of the KLC1-ROS1 fusion–JAK2–STAT3 axis in the regulation of KLC1-ROS1 fusion-induced upregulated oncogenic properties in glioma cells were investigated. This evidence concerns the gene KLC1 and central nervous system cancer.